ArticleWorld journal of urology2026
Reasons for introducing self-intermittent urinary catheterization and long-term outcomes in individuals with multiple sclerosis: a retrospective study.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIndividuals with multiple sclerosis (IwMS) frequently suffer from bladder disorders, and intermittent self-catheterization (ISC) is often part of management. The aim of this study was to determine the main reason for ISC introduction, and assess the outcome of this management at short and long term. METHODOLOGY: A retrospective study included all IwMS who learned ISC between 2018 and 2024. Data were collected upon ISC introduction (T0), 6-12 months later (T1), and at the last follow-up (T2).
resultsOne hundred fifty-nine participants were classified according to the reason for introducing ISC: 23 in the upper urinary tract (UUT) protection group, 26 in the urinary tract infections (UTIs) group, and 110 in the symptoms management group. In the symptoms management group, significant improvements were observed in overactive bladder (OAB) symptoms: nocturia decreased from mean 1.6 (sd 1.5) episodes per night at T0 to 0.5 (0.9) at T1 (p < 10
conclusionISC are mainly initiated to improve OAB symptoms in IwMS, and allow improvement of urinary symptoms, infections, and UUT complications, in association with detrusor overactivity management.
Indexed as
Identifiers
42439943What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.